<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>20105651-40be-4ce3-a274-b50eb83109b1</id>
  <name>COVID_19 ICU Bacterial Infection Order Group</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ï»© Technical Traceability</key>
        <value>{~AHSID~20105651-40be-4ce3-a274-b50eb83109b1~NAME~COVID_19 ICU Bacterial Infection Order Group}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&amp;nbsp;Worsening pneumonia may also be due to inflammation so prolonged antibiotic therapy beyond 5 to&amp;nbsp;7 days in the absence of positive cultures is not currently recommended.&amp;nbsp;&lt;br&gt;Culture directed therapy is preferred. &amp;nbsp;Empiric therapy pending sputum/bronch culture results:&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Empiric therapy pending sputum/bronch culture results&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;ADD if patient not documented as MRSA negative&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;vancomycin IV&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Recommended dosing frequency for vancomycin every 8 to 12 hours. Refer to Bugs and Drugs for frequency adjustments based on creatinine clearance.&amp;nbsp;&lt;/p&gt;&lt;p&gt;Recommended loading dose 25 to 30 mg/kg/dose, maximum 3000 mg/dose.&lt;/p&gt;&lt;p&gt;Recommended maintenance dose 15 mg/kg/dose&lt;/p&gt;&lt;p&gt;(http://ahsweb.ca/HEE/Bugs_and_Drugs)&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;ADD if patient not documented as MRSA negative&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;vancomycin IV&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;vancomycin injection; 25 mg/kg/dose, (max 3000 mg) Intravenous, Once. Discontinue vancomycin or linezolid if MRSA carriage swab and bacterial respiratory cultures are negative for MRSA, STAT&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;ADD if patient not documented as MRSA negative&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;vancomycin IV&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;vancomycin injection; 15 mg/kg/dose, Intravenous, Every 12 hours for 3 days. Starting 12 hours after initial 25 mg/kg/dose dose. Target trough. Reassess in 48 to 72 hours.&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;ADD if patient not documented as MRSA negative&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;vancomycin IV&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Vancomycin Level, Pre-Dose; Per Medication Dosing (Pending Review)&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;ADD if patient not documented as MRSA negative&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;vancomycin IV&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;ADD if patient not documented as MRSA negative&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Linezolid&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;All patients with functional GI tract should use oral formulation, use IV formulation only if non-functional GI tract.&lt;/p&gt;&lt;p&gt;Alternate if renal dysfunction or known prior MRSA pneumonia&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;ADD if patient not documented as MRSA negative&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Linezolid&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;linezolid IV; 600 mg, Intravenous, every 12 hours, for 6 doses.&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;em&gt;Reassess in 48 to 72 hours. Discontinue vancomycin or linezolid if MRSA carriage swab and bacterial respiratory cultures are negative for MRSA. Use IV formulation only if non-functional GI tract. STAT&lt;/em&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;ADD if patient not documented as MRSA negative&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Linezolid&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;linezolid tablet; 600 mg, Oral, every 12 hours, for 6 doses&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;em&gt;Reassess in 48 to 72 hours. Discontinue vancomycin or linezolid if MRSA carriage swab and bacterial respiratory cultures are negative for MRSA.&amp;nbsp;Encouraged for all patients with functional GI tract&lt;/em&gt;.&amp;nbsp;&lt;em&gt;Encouraged for all patients with functional GI tract. STAT&lt;/em&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;ADD if patient not documented as MRSA negative&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Linezolid&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;ADD if patient not documented as MRSA negative&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Management of Possible Secondary Bacterial Infection/Ventilator Associated Pneumonia in Adult COVID-19 patients">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Empiric therapy pending sputum/bronch culture results">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="cbe5b12d-2960-43f4-9c40-f6ae2cc4aee6" concept_name="PHARM meropenem injection Order" max="1" path="/items" name="meropenem injection; 500 mg, intravenous, every 6 hours, for 3 days"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ab1712c1-797c-4370-a11b-a2f0c31cfc8d" concept_name="PHARM piperacillin-tazobactam injection Order" max="1" path="/items" name="piperacillin-tazobactam IV (adult); 4.5 g, intravenous, every 6 hours, for 3 days"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="ADD if patient not documented as MRSA negative">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="vancomycin IV">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="84e61dc2-1c30-4dfe-951a-b67f1fd9a910" concept_name="PHARM vancomycin injection Order" max="1" path="/items" name="vancomycin injection; 25 mg/kg/dose, (max 3000 mg) Intravenous, Once. Discontinue vancomycin or linezolid if MRSA carriage swab and bacterial respiratory cultures are negative for MRSA, STAT"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="FOLLOWED BY"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="84e61dc2-1c30-4dfe-951a-b67f1fd9a910" concept_name="PHARM vancomycin injection Order" max="1" path="/items" name="vancomycin injection; 15 mg/kg/dose, Intravenous, Every 12 hours for 3 days. Starting 12 hours after initial 25 mg/kg/dose dose. Target trough. Reassess in 48 to 72 hours."/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3883821f-01ac-409a-a43d-c581f89f6927" concept_name="LAB Vancomycin Level Pre-Dose [LAB39] IP Order" max="1" path="/items" name="Vancomycin Level, Pre-Dose; Per Medication Dosing (Pending Review)"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Linezolid">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3d7e63db-b139-4aba-aa16-7c732a4b0f77" concept_name="PHARM linezolid injection Order" max="1" path="/items" name="linezolid IV; 600 mg, Intravenous, every 12 hours, for 6 doses."/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="60043240-034a-4384-a0f5-fe03ae49dbd3" concept_name="PHARM linezolid Tablet Order" max="1" path="/items" name="linezolid tablet; 600 mg, Oral, every 12 hours, for 6 doses"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.datetimeorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">37AE50193A7EA542A4F219FF051EE95B</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">5DC6E2FC9E91ADD05E7C5B3E06F83D23</digest>
  </integrity_checks>
</template>